Macrophage-derived Tumor Necrosis Factor-α mediates diabetic renal injury
暂无分享,去创建一个
J. Vacher | S. Nedospasov | W. B. Reeves | F. Farrell | T. Cooper | A. Awad | H. You | Ting Gao | P. Wilkinson | Hanning You | Alaa S. Awad
[1] G. Bruno,et al. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment , 2015, Endocrine.
[2] T. Fujimura,et al. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. , 2014, American journal of physiology. Renal physiology.
[3] S. Chadban,et al. TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy , 2014, PloS one.
[4] W. Liao,et al. Biologic therapy in erythrodermic and pustular psoriasis. , 2014, Journal of drugs in dermatology : JDD.
[5] T. Cooper,et al. Macrophages directly mediate diabetic renal injury. , 2013, American journal of physiology. Renal physiology.
[6] Beilei Lei,et al. Tumor necrosis factor alpha antagonism improves neurological recovery in murine intracerebral hemorrhage , 2013, Journal of Neuroinflammation.
[7] S. Morris,et al. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism , 2013, Kidney international.
[8] K. Lai,et al. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. , 2013, Kidney international.
[9] P. V. Schouwenburg,et al. Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis , 2013, Nature Reviews Rheumatology.
[10] H. Freeman,et al. Use of the tumor necrosis factor-blockers for Crohn's disease. , 2012, World journal of gastroenterology.
[11] E. Abdel-Rahman,et al. Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches , 2012, Journal of General Internal Medicine.
[12] T. Mayadas,et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.
[13] T. Mayadas,et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.
[14] M. Okusa,et al. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. , 2011, American journal of physiology. Renal physiology.
[15] S. Morris,et al. Arginase-2 Mediates Diabetic Renal Injury , 2011, Diabetes.
[16] P. Tobias,et al. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. , 2011, Cytokine.
[17] J. Navarro-González,et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.
[18] T. Greene,et al. Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design , 2011, BMC nephrology.
[19] D. Williamson,et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.
[20] M. Graham,et al. Evaluation of an Anti-Tumor Necrosis Factor Therapeutic in a Mouse Model of Niemann-Pick C Liver Disease , 2010, PloS one.
[21] C. Alpers,et al. Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[22] George Kollias,et al. The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. , 2009, The Journal of clinical investigation.
[23] G. Camussi,et al. Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes , 2009, Diabetes.
[24] S. Leroy,et al. Successful Anti‐TNFα Treatment in a Child with Posttransplant Recurrent Focal Segmental Glomerulosclerosis , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] T. Yoo,et al. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. , 2008, American journal of physiology. Renal physiology.
[26] GH Tesch. ROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES , 2007, Clinical and experimental pharmacology & physiology.
[27] P. Goldstraw,et al. Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages1 , 2007, The Journal of Immunology.
[28] K. Nomura,et al. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus , 2006, Clinical and Experimental Nephrology.
[29] N. Sheerin,et al. Toll‐like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products , 2006, Clinical and experimental immunology.
[30] R. Atkins,et al. Macrophage accumulation in human progressive diabetic nephropathy , 2006, Nephrology.
[31] Liping Huang,et al. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. , 2006, American journal of physiology. Renal physiology.
[32] R. Atkins,et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. , 2005, Journal of the American Society of Nephrology : JASN.
[33] J. Vacher,et al. Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice , 2005, Genesis.
[34] S. Kelsen,et al. Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells , 2004, European Respiratory Journal.
[35] D. Raveh,et al. Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome , 2004, Pediatric Nephrology.
[36] K. Wu,et al. Dual Regulation of Tumor Necrosis Factor-α-Induced CCL2/Monocyte Chemoattractant Protein-1 Expression in Vascular Smooth Muscle Cells by Nuclear Factor-κB and Activator Protein-1: Modulation by Type III Phosphodiesterase Inhibition , 2004, Journal of Pharmacology and Experimental Therapeutics.
[37] F. Gesek,et al. Pentoxifylline Ameliorates Renal Tumor Necrosis Factor Expression, Sodium Retention, and Renal Hypertrophy in Diabetic Rats , 2004, American Journal of Nephrology.
[38] F. Gesek,et al. Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. , 2004, Kidney international.
[39] R. Schnellmann,et al. Role of an Endoplasmic Reticulum Ca2+-Independent Phospholipase A2 in Cisplatin-Induced Renal Cell Apoptosis , 2004, Journal of Pharmacology and Experimental Therapeutics.
[40] G. Ramesh,et al. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. , 2003, American journal of physiology. Renal physiology.
[41] H. Siragy,et al. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. , 2003, Kidney international.
[42] F. Thaiss,et al. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. , 2002, Kidney international.
[43] G. Ramesh,et al. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity , 2002 .
[44] J. Skepper,et al. Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants , 2001, Laboratory Investigation.
[45] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[46] M. Perretti,et al. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. , 1999, Biochemical and biophysical research communications.
[47] M. Perretti,et al. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. , 1999, Journal of immunology.
[48] H. Makino,et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy , 1998, Diabetologia.
[49] L. Owen-Schaub,et al. Human Tumor Necrosis Factor Receptor p75/80 (CD120b) Gene Structure and Promoter Characterization* , 1996, The Journal of Biological Chemistry.
[50] K. Yoshinaga,et al. The role of macrophages in diabetic glomerulosclerosis. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[51] Y. Tomino,et al. mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats , 1993, Diabetes.
[52] M. Kondo,et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. , 1991, Kidney international.
[53] P. Tipping,et al. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[54] Z. Hruby,et al. Spontaneous release of tumor necrosis factor alpha by isolated renal glomeruli and cultured glomerular mesangial cells. , 1991, Clinical immunology and immunopathology.
[55] A Bohle,et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. , 1991, Pathology, research and practice.
[56] Leonard,et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.
[57] J. Oudinet,et al. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. , 1989, Kidney international.
[58] C. Nathan,et al. Secretory products of macrophages. , 1987, The Journal of clinical investigation.
[59] J. Navarro-González,et al. Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. , 2015, Journal of the American Society of Nephrology : JASN.
[60] Jagdeep Nanchahal,et al. Anti-TNF therapy: past, present and future. , 2015, International immunology.
[61] K. Chan,et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[62] H. Anders,et al. Cardiovascular , Pulmonary and Renal Pathology Late Onset of Ccl 2 Blockade with the Spiegelmer mNOX-E 36 – 3 PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db / db Mice , 2010 .
[63] R. Atkins,et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.
[64] H. Parving,et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. , 2006, Diabetes care.
[65] B. Ryffel,et al. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.
[66] D. Raveh,et al. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. , 2004, Pediatric nephrology.
[67] S. Kelsen,et al. Regulation of interleukin-1beta and interleukin-1beta inhibitor release by human airway epithelial cells. , 2004, The European respiratory journal.
[68] F. Gesek,et al. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. , 2003, American journal of physiology. Renal physiology.
[69] M. Kakei,et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. , 2003, Journal of diabetes and its complications.
[70] E. Lerut,et al. Benefit of anti-TNF a treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis , 2003 .
[71] G. Ramesh,et al. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. , 2002, The Journal of clinical investigation.
[72] C. Tsai,et al. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. , 1996, Nephron.